Yagmurdur M C, Emiroğlu R, Ayvaz I, Sozen H, Karakayali H, Haberal M
Baskent University Faculty of Medicine, Department of General Surgery Division of Transplantation, Ankara Turkey.
Transplant Proc. 2005 Sep;37(7):2957-61. doi: 10.1016/j.transproceed.2005.07.022.
We retrospectively evaluated the long-term results of 53 (3.5%) recipients who received second allograft among 1486 kidney transplants between November 3, 1975 and June 30, 2004. Two study groups were patients in Group 1 (n = 21) who underwent allograft nephrectomy and those in Group 2 (n = 32) who did not. We assessed demographic features, rejection rates throughout the follow-up period, and serum creatinine levels at 12 months as well as graft and patient survival rates, postoperative complications, time interval between transplantations, and HLA matches. Forty-three patients who underwent retransplantation received kidneys from living-related donors and the remaining 10 from cadaveric donors. Mean serum creatinine levels of Group 1 versus Group 2 were 1.8 mg/dL (range, 0.8 to 6.6 mg/dL) versus 2.1 +/- 1.1 mg/dL (range, 1.1 to 7.1 mg/dL). HLA-AB and HLA-DR mismatches were 1.9 +/- 1.1 versus 1 +/- 0.6, respectively (P = .01). Acute rejection rates were not significantly different between Groups 1 (9/21, 43%) and 2 (12/32, 38%) (P < .05). The average intervals between the first and the second transplantations were 62 +/- 26 months in Group 1 (P = .02) and 32 +/- 11 months in Group 2. One-, 3-, and 5-year graft survival rates in Group 1 versus Group 2 were 83% versus 89% (P > .05); 64% versus 79% (P > .05), and 45% versus 68% (P = .04), respectively. In conclusion, we did not observe any advantage of graft nephrectomy before retransplantation. The length of the interval between the first and the second transplantations may have a negative correlation with second graft survival.
我们回顾性评估了1975年11月3日至2004年6月30日期间1486例肾移植受者中53例(3.5%)接受第二次同种异体移植的长期结果。两个研究组分别为:第1组(n = 21)接受同种异体肾切除术的患者和第2组(n = 32)未接受同种异体肾切除术的患者。我们评估了人口统计学特征、整个随访期的排斥率、12个月时的血清肌酐水平以及移植肾和患者的生存率、术后并发症、两次移植之间的时间间隔和HLA配型情况。43例接受再次移植的患者接受了来自亲属活体供者的肾脏,其余10例接受了尸体供者的肾脏。第1组与第2组的平均血清肌酐水平分别为1.8mg/dL(范围0.8至6.6mg/dL)和2.1±1.1mg/dL(范围1.1至7.1mg/dL)。HLA-AB和HLA-DR错配分别为1.9±1.1和1±0.6(P = 0.01)。第1组(9/21,43%)和第2组(12/32,38%)的急性排斥率无显著差异(P < 0.05)。第1组第一次和第二次移植之间的平均间隔为62±26个月(P = 0.02),第2组为32±11个月。第1组与第2组的1年、3年和5年移植肾生存率分别为83%对89%(P > 0.05);64%对79%(P > 0.05)和45%对68%(P = 0.04)。总之,我们未观察到再次移植前进行移植肾切除术有任何优势。第一次和第二次移植之间的时间间隔长短可能与第二次移植肾的存活呈负相关。